The top 3 reasons why global pharmaceutical companies, biotechnology startups, and venture capital and private equity firms alike choose Certara:
1. Clients and partners choose us for our quantitative-driven approach. 당사는 전체 신약 개발 수명 주기에 걸쳐 모델링 및 시뮬레이션을 사용하여 프로그램의 위험을 낮추고 중요한 의사결정에 대한 확신을 강화하여 더 현명하고 신속하게 목표를 달성하도록 돕습니다.
2. We have the most experienced (and largest) team of experts with clinical pharmacologists, pharmacometricians, and regulatory scientists and writers, that is dedicated to achieve your success. Building relationships between our experts and your team is our focus. This is the reason our top 30 customers by revenue in 2022 have been with us for more than ten years on average.
3. Our proven track record speaks for itself. Certara는 종양학, 희귀 질환, 전염병, 신경퇴행성 질환 등 성공적인 협력을 통한 사례 연구 라이브러리를 보유하고 있습니다. Since 2014, customers who use our biosimulation software and technology-driven services have received 90% of all new drug approvals by the U.S. Food and Drug Administration (“FDA”).
임상 약리학
Certara의 임상 약리학 전문성은 신약 개발에서 안전성과 유효성을 최적화하는 데 있어 매우 중요합니다. 임상 약리학은 약물 라벨의 50% 이상을 구성합니다.
신약 개발 및 규제 제출물
Certara의 입증된 정량적 시스템과 통합 접근 방식은 점점 더 복잡해지는 신약 개발 환경을 탐색하고 성공 가능성을 극대화할 수 있도록 지원합니다.
Drug Development Stewardship
Our R&D Program Leaders worldwide partner with clients to develop key decision criteria and help facilitate decision-making throughout your drug development program.
Program Management
We provide skilled management outsourcing support for your function or department. Our team offers end-to-end project management expertise and excellence in both early and late-stage drug development programs.
Clinical Science
Certara’s clinical scientists provide clinical oversight from beginning to end and design your clinical development program to achieve your goals.
Clinical Pharmacology Study Execution Team
The expertise and experience to set up your clinical pharmacology program for success. We can help ensure that your CRO does everything correctly, efficiently, and not more than is needed.
Early Development/Investigational New Drug (IND) Enabling Services
Get peace of mind now. Our clients benefit from complete analysis of safety issues to prevent timeline delays and apply unique study designs to move faster into the proof-of-concept (POC) clinical studies.
Since 2014, our customers have received over 90% of new drug and biologic approvals by the FDA. These FDA approvals span across several designations and therapeutic areas, including oncology, infectious disease, hematology, pulmonology, cardiology, dermatology, diabetes, neurology, gastroenterology, psychiatry, bone, migraine, sleep disorders and more. View the case studies below to see for yourself.
Certara는 동급 최고의 능력을 활용하여 모델링 및 시뮬레이션, 규제 과학, 시장 접근성 영역에서 귀하의 팀과 협력해 중요한 결정을 위한 정보를 제공하고 규제 준수와 상업적 성공을 위한 준비를 완료해 드립니다.
파트너십의 성공에 있어 애질리티, 커뮤니케이션, 품질 및 신뢰가 가장 중요합니다. 귀사와 함께 협력하여 위험을 예측하고 강력한 전략을 수립하며 원활하게 구현할 수 있도록 하는 응집력 있는 하나의 통합된 팀입니다.
